Trump’s Tariffs Set to Hit Ireland, Where Drugmakers Play Tax Games

The article discusses the potential impact of President Trump's tariffs on Ireland, where many American drug companies have set up operations to take advantage of the country's favorable tax policies. Ireland has been a hub for pharmaceutical manufacturing, allowing these companies to pay lower taxes. However, the article suggests that this strategy may no longer be as effective in the face of Trump's tariffs. The article highlights that the manufacturing operations in Ireland were designed for a world without these tariffs, and the new trade policies could disrupt this arrangement. This could have significant implications for the pharmaceutical industry, which has relied on Ireland's tax advantages to boost profits. The article does not take a partisan stance, but rather presents the potential challenges that drug companies may face as a result of the changing trade landscape.